Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Dexmedetomidine for Sympathetic Control in Craniotomy
NCT02563288Phase 3Unknown
- Sponsor
- G. Papanikolaou General Hospital
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Esmolol Arm with Dexmedetomidine Arm (2 arms). Primary endpoint: Mean Arterial Pressure. Status: unknown.
02
Drugs
esmololdexmedetomidine
Beyond the preview
Go deeper on NCT02563288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563288.